BeyondSpring Presents EfficacySafety Results from a Phase 2 Study of Pembrolizumab plus PlinabulinDocetaxel in Metastatic NSCLC after Progressing on First-Line Immune Checkpoint Inhibitors at ESMO Congress 2024
BYSI Stock | USD 1.64 0.07 4.09% |
Under 54% of BeyondSpring's investor base is interested to short. The analysis of the overall investor sentiment regarding BeyondSpring suggests that many traders are impartial. BeyondSpring's investing sentiment shows overall attitude of investors towards BeyondSpring.
BeyondSpring |
Median PFS at 8.63 months and Disease Control Rate of 89.5 percent in Previously Treated NSCLC Patients after Progression on PD-1L1 Monotherapy or in Combination with Platinum Doublet ChemotherapyFLORHAM PARK, N.J., Sept. 16, 2024 -- BeyondSpring Inc. , a clinical-stage global biopharmaceutical company developing innovative cancer therapies, today presented interim phase 2 data on the 303 Study, a study in 2L3L non-small cell lung cance
Read at finance.yahoo.com
BeyondSpring Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards BeyondSpring can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BeyondSpring Fundamental Analysis
We analyze BeyondSpring's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeyondSpring using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeyondSpring based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
BeyondSpring is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
BeyondSpring Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeyondSpring stock to make a market-neutral strategy. Peer analysis of BeyondSpring could also be used in its relative valuation, which is a method of valuing BeyondSpring by comparing valuation metrics with similar companies.
Peers
BeyondSpring Related Equities
ARMP | Armata Pharmaceuticals | 4.29 | ||||
ADTX | Aditxt | 2.94 | ||||
MCRB | Seres Therapeutics | 2.33 | ||||
SRZN | Surrozen | 1.44 | ||||
SLS | Sellas Life | 1.16 | ||||
FBRX | Forte Biosciences | 0.52 | ||||
KTTA | Pasithea Therapeutics | 0.75 | ||||
INKT | Mink Therapeutics | 1.59 | ||||
PLX | Protalix Biotherapeutics | 1.64 | ||||
ALVR | Allovir | 2.17 | ||||
MIST | Milestone Pharmaceuticals | 3.23 | ||||
ONCY | Oncolytics Biotech | 3.57 | ||||
SCPH | Scpharmaceuticals | 3.63 | ||||
RVPH | Reviva Pharmaceuticals | 5.78 | ||||
EYPT | Eyepoint Pharmaceuticals | 6.05 | ||||
CADL | Candel Therapeutics | 31.12 |
Complementary Tools for BeyondSpring Stock analysis
When running BeyondSpring's price analysis, check to measure BeyondSpring's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BeyondSpring is operating at the current time. Most of BeyondSpring's value examination focuses on studying past and present price action to predict the probability of BeyondSpring's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BeyondSpring's price. Additionally, you may evaluate how the addition of BeyondSpring to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Transaction History View history of all your transactions and understand their impact on performance |